Navigation Links
CSM Announces Promotion of Brian Swites to President
Date:4/4/2016

CSM, a leading clinical trial supply company, today announced the promotion of Brian Swites to President, effective immediately. In his new role, Swites will oversee the company’s global capabilities, strategic partnerships, and ensure overall growth and performance goals are being met.

“Brian has the management skills and expertise necessary to drive CSM’s future growth and continue to move our On-Demand platform forward,” said Gerald Finken, CEO of CSM. “His promotion will allow me to step up and pursue my vision of incorporating the practice of pharmacy into clinical research to ensure better patient outcomes. With these changes, CSM will maintain its position as the industry’s innovative leader in clinical supplies.”

Swites joined the CSM team in January 2015 and has since held a series of leadership roles, most recently serving as Vice President of Operations. He has over 30 years of biopharmaceutical industry experience, specializing in global clinical supply chain management.

Prior to joining CSM, Swites held various management positions during his 13 years at Cephalon, Inc. and Teva Pharmaceuticals Industries, Ltd. He received his Master's Degree in Pharmaceutical Manufacturing from the Stevens Institute of Technology.

“I’m very excited about this opportunity and feel my 30 years of experience in clinical supplies will allow me to successfully support and guide the organization,” said Swites. “As President, I will continue to support our strategic plan, raise the bar of excellence, and bring CSM to the next level of growth. This will be done by capitalizing on the existing On-Demand platform, expanding our global capabilities and leading industry innovation with offerings such as direct-to-patient shipping.”

CSM recently underwent a major expansion effort, opening a state-of-the-art clinical trial supply facility in Malvern, Pennsylvania. Swites’ role will be crucial in supporting CSM’s future growth, which incudes adding multiple locations throughout the U.S.

Swites added, “We have some of the best people in the industry at CSM and I’m proud to be leading them into our next phase of evolution.”

About CSM
CSM provides packaging, storage, and distribution services with quality-driven processes to enhance biotechnology and pharmaceutical clinical trials worldwide. The company has continued to evolve with its blend of unique and traditional clinical trial services that improve efficiency and accuracy.
CSM is the innovator of On-Demand Packaging and Labeling services, an industry breakthrough in which clinical supplies are made specifically for, and immediately prior to, each shipment. Some of CSM’s other core services include: traditional packaging and labeling, cold chain logistics, controlled drug services, returns and reconciliation, clinical label printing, and global distribution. For more information, visit http://www.csmondemand.com.

###

Read the full story at http://www.prweb.com/releases/2016/04/prweb13312113.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Rocky Mountain Biologicals Announces Water for Injection (WFI) Manufacturing Facility in West Jordan, Utah
2. Temarry Recycling Announces That Exporting Hazardous Waste Eliminates Biennial Reporting Requirement
3. Charm Sciences Announces FDA Release of 2400 Forms for Charm Peel Plate AC and EC Microbial Tests
4. CfPIE Announces New Training Course on the Regulated Medical Marijuana Business
5. Global Stem Cells Group Announces Manufacturing Phase of Progenikine™ SVF Closed System
6. TEDxASU Announces World Renowned Virology Expert, Dr. Betram Jacobs, PhD, as Speaker for First ASU TEDx Event
7. BioLineRx Announces Initiation of Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization Treatment
8. ProMIS Neurosciences Announces FY2015 Year End Results
9. Maxwell Biotech Venture Funds Portfolio Company Hepatera LLC Announces Start of Phase 2b Clinical Trial of Myrcludex B
10. DNA2.0 Announces Opening of European Office in Basel, Switzerland
11. WFU Announces Biomedical Sciences And Engineering Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2018)... , ... September 12, 2018 , ... ... a quality management professional and former Senior Director of Regulatory Affairs and Quality ... , As Senior Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., ...
(Date:9/7/2018)... , ... September 06, 2018 , ... ... fatal neuromuscular disease, has been validated to be as effective as manual pathology. ... Dystrophin Staining in Frozen Muscle Biopsies,” was published in the Archives of Pathology ...
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more than ... getting connected, too. Draper’s latest system is tiny in size, but is poised to ... factor in the new implant design is the growing awareness that disease often involves ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO and founder ... safety study performed on an allogeneic (donor derived) stem cell product for osteoarthritis ... conference in September. He is also the organizer of Breakout Session 4: ...
Breaking Biology Technology:
(Date:8/21/2018)... ... August 20, 2018 , ... When designing a fluidic system ... must ensure what is designed can be manufactured reliably and cost effectively while ... flow path design with specific focus on layered manifold technology. , Layered manifold ...
(Date:8/21/2018)... (PRWEB) , ... August 21, 2018 , ... ... throughput screening (HTS) solutions, Bellbrook Labs is dedicated to offering customers a successful ... assays, visitors will find a seamless transition between products, with relevant details such ...
(Date:8/17/2018)... ... August 16, 2018 , ... With increasing safety requirements, and ... research projects, are presenting multiple challenges. To be successful in such a competitive environment, ... different aspects of the multiple tasks needed to develop a new drug or to ...
Breaking Biology News(10 mins):